Arsenic and retinoic acid, towards oncogene-targeted treatments of acute promyelocytic leukemia;Arsenic et acide rétinoïque, vers des traitements ciblés de la leucémie aiguë promyélocytaire ?

Bulletin de l'Academie Nationale de Medecine

Volumn 182, Issue 1, 1998, Pages 63-71

  De Thé, Hugues ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Leukemia, promyelocytic, acute, therapeutics; Oncogenes; Receptors, retinoic acid, metabolism; Translocation (genetics)

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENIC; RETINOIC ACID;

HUMAN; PROMYELOCYTIC LEUKEMIA; REVIEW;

ANTINEOPLASTIC AGENTS; ARSENIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; TRETINOIN;

EID: 0031610557     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. RABBITTS Th. - Chromosomal translocations in human cancer. Nature, 1994, 372, 143-149.
2. DE THÉ H., LAVAU C., MARCHIO A., CHOMIENNE C., DEGOS L., DEJEAN A. - The PML-RAR alpha fusion mRNA generated by the t(15 ; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 1991, 66, 675-84.
3. KAKIZUKA A., MILLER W. Jr., UMESONO K., WARRELL R. Jr., FRANKEL Sr., MURTY VV., DMITROVSKY E., EVANS RM. - Chromosomal translocation t(15 ; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell, 1991, 66, 663-74.
4. GODDARD A.D., BORROW J., FREEMONT P.S., SOLOMON E. - Characterization of a zinc finger gene disrupted by the t(15 ; 17) in acute promyelocytic leukemia. Science, 1991, 254, 1371-1374.
5. LE DOUARIN B., ZECHEL C., GARNIER J-M., LUTZ Y., TORA L., PIERRAT B., HEERY D., GRONEMEYER H., CHAMBON P., LOSSON R. - The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. Embo J., 1995, 14, 2020-2033.
6. WARRELL R., DE THÉ H., WANG Z., DEGOS L. - Acute promyelocytic leukemia. New Engl. J. Med., 1993, 329, 177-189.
7. GRISOLANO J.L., WESSELSCHMIDT R.L., PELICCI P.G., LEY T.J. - Altered myeloid development and acute leukemia in transgenic mice expressing PML-RARalpha under control of cathepsin G regulatory sequences. Blood, 1997, 89, 376-387.
8. BROWN D., KOGAN S., LAGASSE E., WEISSMAN I., ALCALAY M., PELICCI P.G., ATWATER S., BISHOP J.M. - A PML RAR alpha transgene initiates murine acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 1997, 94, 2551-2556.
9. GANDRILLON O., RASCLE A., SAMARUT J. - The v-erbA oncogene : a superb tool for dissecting the involvement of nuclear hormone receptors in differentiation and neoplasia (Review). Int. J. Oncol., 1995, 6, 215-231.
10. CHEN Z., BRAND N., CHEN A., CHEN S., TONG J., WANG Z., WAXMAN S., ZELENT A. - Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor a locus due to a variant t(11, 17) translocation in acute promyelocytic leukemia. Embo J., 1993, 12, 1161-1167.
11. LICHT J.D., CHOMIENNE C., GOY A., CHEN A., SCOTT A.A., HEAD D.R., MICHAUX J.L., WU Y., DE BLASIO A., MILLER Jr W.H., ZELENETZ A.D., WILLMAN C.L., CHEN Z., CHEN S-J., ZELENT A., MACINTYRE E., VEIL A., CORTES J., KANTARJIAN H., WAXMAN S. - Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11 ; 17). Blood, 1995, 55, 1083-1094.
12. REDNER R.L., RUSH E.A., FAAS S., RUDERT W.A., COREY S.J. - The t(5-17) variant of acute promyelocytic leukemia expresses a nucleophosmin retinoic acid receptor fusion. Blood, 1996, 87, 882-886.
13. NERVI C., POINDEXTER E.C., GRIGNANI F., PANDOLFI P.P., LO COCO F., AVVISATI G., PELICCI P.G., JETTEN A.M. - Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15 ; 17) translocation. Cancer Res., 1992, 52, 3687-92.
14. PEREZ A., KASTNER P., SETHI S., LUTZ Y., REIBEL C., CHAMBON P. - PML/RAR homodimers : distinct binding properties and heteromeric interactions with RXR. Embo J., 1993, 12, 3171-3182.
15. TSAI S., COLLINS S. - A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocytic stage. Proc. Natl. Acad. Sci. USA., 1993, 90, 7153-7157.
16. TSAI S., BARTELMEZ S., HEYMAN R., DAMM K., EVANS R., COLLINS S.J. - A mutated retinoic acid receptor a exhibiting dominant - negative activity alters the lineage development of a multipotent hematopoietic cell line. Genes & Dev., 1993, 6, 2258-2269.
17. TSAI S., BARTELMEZ S., SITNICKA E., COLLINS S. - Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development. Genes & Development, 1994, 8, 2831-2841.
18. GRIGNANI F., FERRUCCI P., TESTA U., TALAMO G., FAGIOLI M., ALCALAY M., MENCARELLI A., GRIGNANI F., PESCHLE C., NICOLETTI I., PEUCCI P. - The acute promyelocytic leukemia specific PML/RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell, 1993, 74, 423-431.
19. EILERS M., PICARD D., YAMAMOTO K., BISHOP J. - Chimaeras of myc oncoprotein and steroid receptors cause hormone dependent transformation of cells. Nature, 1989, 340, 66-68.
20. DE THÉ H., KOKEN M., STADLER M., DANIEL M.T., PUVION E., CHOMIENNE C., DEGOS L. - Un nouveau compartiment nucléaire, révélé par les autoanticorps de la cirrhose biliaire primitive, pourait être impliqué dans la pathogénie de la leucémie aiguë promyélocytaire. Médecine/Science, 1994, 10, 577-582.
21. DOUCAS V., EVANS R.M. - The PML nuclear compartment and cancer (review). Biochim. Biophys. Acta. Rev. Cancer, 1996, 1288, M 25-M 29.
22. STADLER M., CHELBI-ALIX M.K., KOKEN M.H.M., VENTURINI L., LEE C., SAÏB A., QUIGNON F., PELICANO L., GUILLEMIN M-C., SCHINDLER C., DE THÉ H. - Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene, 1995, 11, 2565-2573.
23. MU Z.M., CHIN K.V., LIU J.H., LOZANO G., CHANG K.S. - PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell. Biol., 1994, 14, 6858-6867.
24. KOKEN M.H.M., PUVION-DUTILLEUL F., GUILLEMIN M.C., VIRON A., LINARES-CRUZ G., STUURMAN N., DE JONG L., SZOSTECKI C., CALVO F., CHOMIENNE C., DEGOS L., PUVION E., DE THÉ H. - The t(15 ; 17) translocation alters a nuclear body in a RA-reversible fashion. Embo J., 1994, 13, 1073-1083.
25. DYCK J.A., MAUL G.G., MILLER W.H., CHEN J.D., KAKIZUKA A., EVANS R.M. - A novel macromolecular structure is a target of the promyelocyte - retinoic acid receptor oncoprotein. Cell, 1994, 76, 333-343.
26. QUIGNON F., CHEN Z., DE THÉ H. - Retinoic acid and arsenic : towards oncogene targeted treatments of acute promyelocytic leukaemia. Biochim. Biophys. Acta. rev. in cancer, 1997, in press.
27. DEGOS L. - Differentiation therapy of leukaemia. Leukaemia, 1993, 7, 766-770.
28. KASTNER P., MARK M., CHAMBON P. - Nonsteroid nuclear receptors : what are genetic studies telling us about their role in real life ? (review). Cell, 1995, 83, 859-869.
29. FENAUX P., CHOMIENNE C., DEGOS L. - Acute promyelocytic leukemia : biology and treatment. Semin. Oncol., 1997, 24, 92-102.
30. ZHANG P., WANG S.Y., HU L.H., SHI F.D., QIU F.D., HONG R.J., HAN X.Y., YANG H.F., SONG Y.Z., LIU Y.P., ZHOU J., JIN Z.J. - Treatment of acute promyelocytic leukaemia with intravenous arsenic trioxide. Chin. J. Hematol., 1996, 17, 58-60.
31. SUN H.D., MA L., HU H.X., ZHANG T.D. - Use of Ai-Ling n.1 injection, combined with pattern identification theory of chinese traditional medicine, in the treatment of acute promyelocytic leukemia : report from 32 patients. Chin. J. Integrat. Chin. & West. Med., 1992, 12, 170-171.
32. ESPINOZA E., MANN M., BLEASDELL B. - Arsenic and mercury in traditional chinese herbal balls. New Engl. J. Med., 1995, 333, 803-804.
33. HUANG M., YE Y., CHEN R., CHAI J., LU J., ZHOA L., GU L., WANG Z. - Use of all trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood, 1988, 72, 567-572.
34. 4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 1996, 88, 1052-1061.
35. 3 exerts dose-dependent dual effects on APL cells. Blood, 1997, 89, 3345-3353.
36. YOSHIDA H., KITAMURA K., TANAKA K., OMURA S., MIYAZAKI T., HACHIYA T., OHNO R., NAOE T. - Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-transretinoic acid in acute promyelocytic leukemia. Possible role of the proteasome pathway. Cancer Res., 1996, 56, 2945-2948.
37. WEIS K., RAMBAUD S., LAVAU C., JANSEN J., CARVALHO T., CARMO-FONSECA M., LAMOND A., DEJEAN A. - Retinoic acid regulates aberrant nuclear localization of PML/RARα in acute promyelocytic leukemia cells. Cell, 1994, 76, 345-356.
38. LANOTTE M., MARTIN-THOUVENIN V., NAJMAN S., BALERINI P., VALENSI F., BERGER R. - NB4, a maturation inducible cell line with t(15 ; 17) marker isolated from a human acute promyelocytic leukemia. Blood, 1991, 77, 1080-1086.
39. ZHU J., KOKEN M.H.M., QUIGNON F., CHELBI-ALIX, M.K., DEGOS L., WANG Z.Y., CHEN Z., DE THÉ H. - Arsenic-induced PML targeting onto nuclear bodies : implications for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad. Sci. USA, 1997, 94, 3978-3983.